Kumo Launches KumoRFM-2, A Foundation Model Built to Replace Traditional Enterprise Machine Learning
Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...
The semiconductor industry, as always, is at the forefront of transformational technological innovation, driving escalating complexity of manufacturing processes that extend time-to-market delivery, ...
Dynamic prediction of cancer-associated thrombosis to guide prophylactic anticoagulation. Age distribution of metastatic cancer patients and chemotherapy discontinuation rates.
Immunotherapy at the end of life. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a full text component.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results